BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...founder at antibody companies Cambridge Antibody Technology Group plc, which AstraZeneca plc (LSE:AZN, NYSE:AZN) acquired; Domantis Ltd....
BioCentury | Sep 7, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...founder at antibody companies Cambridge Antibody Technology Group plc, which AstraZeneca plc (LSE:AZN, NYSE:AZN) acquired; Domantis Ltd....
BioCentury | Sep 4, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...founder at antibody companies Cambridge Antibody Technology Group plc, which AstraZeneca plc (LSE:AZN, NYSE:AZN) acquired; Domantis Ltd....
BioCentury | Aug 1, 2018
Emerging Company Profile

Connecting the DotBodies

...step that DotBodies should not. At least two other companies, Crescendo Biologics Ltd. and the Domantis Ltd....
...cancer. GSK spokesperson Mary Anne Rhyne declined to disclose indications or stages of development for Domantis’...
...problem DotBio overcomes in its initial screening. Rhyne said GSK has published several papers on Domantis’...
BioCentury | Feb 2, 2015
Company News

Ablynx, GlaxoSmithKline antibodies news

...Division of the European Patent Office (EPO) to revoke European Patent No. EP1517921 from GlaxoSmithKline’s Domantis Ltd....
BioCentury | Oct 21, 2010
Tools & Techniques

Crescendo's TKO

...the Domantis Ltd. unit of GlaxoSmithKline plc and Ablynx N.V. The Domain Antibodies (dAbs) platform from Domantis...
...Fragment approaches Crescendo hopes the triple knockouts will give it a competitive advantage over the Domantis...
BioCentury | May 31, 2010
Finance

Performance Counts

...would dispute that, and that is an important space. And there was Domantis as well." Domantis Ltd....
BioCentury | May 17, 2010
Emerging Company Profile

Crescendo: Best of Both Fragments

...CSO Mike Romanos told BioCentury. Domain antibodies (dAbs) are human antibody fragments created by the Domantis Ltd....
BioCentury | Feb 22, 2010
Company News

Ablynx, GlaxoSmithKline antibodies news

...Opposition Division of the European Patent Office (EPO) revoked European Patent No. EP1517921 from GlaxoSmithKline's Domantis Ltd....
...other Nanobodies. A Nanobody is a functional antigen-binding domain derived from an antibody heavy chain. Domantis...
BioCentury | Nov 2, 2009
Emerging Company Profile

Bicycle Therapeutics: Peddling peptides

...of antibody companies Cambridge Antibody Technology Group plc (now part of AstraZeneca plc ) and Domantis Ltd....
Items per page:
1 - 10 of 77
BioCentury | Oct 3, 2018
Politics & Policy

Phage display founders win Nobel for chemistry

...founder at antibody companies Cambridge Antibody Technology Group plc, which AstraZeneca plc (LSE:AZN, NYSE:AZN) acquired; Domantis Ltd....
BioCentury | Sep 7, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...founder at antibody companies Cambridge Antibody Technology Group plc, which AstraZeneca plc (LSE:AZN, NYSE:AZN) acquired; Domantis Ltd....
BioCentury | Sep 4, 2018
Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

...founder at antibody companies Cambridge Antibody Technology Group plc, which AstraZeneca plc (LSE:AZN, NYSE:AZN) acquired; Domantis Ltd....
BioCentury | Aug 1, 2018
Emerging Company Profile

Connecting the DotBodies

...step that DotBodies should not. At least two other companies, Crescendo Biologics Ltd. and the Domantis Ltd....
...cancer. GSK spokesperson Mary Anne Rhyne declined to disclose indications or stages of development for Domantis’...
...problem DotBio overcomes in its initial screening. Rhyne said GSK has published several papers on Domantis’...
BioCentury | Feb 2, 2015
Company News

Ablynx, GlaxoSmithKline antibodies news

...Division of the European Patent Office (EPO) to revoke European Patent No. EP1517921 from GlaxoSmithKline’s Domantis Ltd....
BioCentury | Oct 21, 2010
Tools & Techniques

Crescendo's TKO

...the Domantis Ltd. unit of GlaxoSmithKline plc and Ablynx N.V. The Domain Antibodies (dAbs) platform from Domantis...
...Fragment approaches Crescendo hopes the triple knockouts will give it a competitive advantage over the Domantis...
BioCentury | May 31, 2010
Finance

Performance Counts

...would dispute that, and that is an important space. And there was Domantis as well." Domantis Ltd....
BioCentury | May 17, 2010
Emerging Company Profile

Crescendo: Best of Both Fragments

...CSO Mike Romanos told BioCentury. Domain antibodies (dAbs) are human antibody fragments created by the Domantis Ltd....
BioCentury | Feb 22, 2010
Company News

Ablynx, GlaxoSmithKline antibodies news

...Opposition Division of the European Patent Office (EPO) revoked European Patent No. EP1517921 from GlaxoSmithKline's Domantis Ltd....
...other Nanobodies. A Nanobody is a functional antigen-binding domain derived from an antibody heavy chain. Domantis...
BioCentury | Nov 2, 2009
Emerging Company Profile

Bicycle Therapeutics: Peddling peptides

...of antibody companies Cambridge Antibody Technology Group plc (now part of AstraZeneca plc ) and Domantis Ltd....
Items per page:
1 - 10 of 77